National Science Foundation

Novaurum Biosciences specializes in the development of AuPEC, a cell-based encapsulation technology aimed at enhancing the performance of implanted medical devices. This innovative platform integrates microbiology and nanotechnology to create nano-biological coatings for orthopedic implants. By reducing infection rates and promoting tissue regeneration, Novaurum's technology enables medical professionals to improve patient outcomes significantly. The company's approach offers a novel solution for addressing common challenges associated with implantable devices, ultimately contributing to safer and more effective medical interventions.

Dynocardia, Inc. is a biomedical device company based in Massachusetts that specializes in wireless blood pressure measurement equipment. Founded in 2018, the company has developed a wrist-wearable device called ViTrack, which allows users to accurately and continuously measure vital health parameters, including blood pressure, heart rate, heart rhythm, and respiration rate. Utilizing an innovative optomechanical sensor, Dynocardia's technology offers a non-invasive method for blood pressure measurement, rivaling the accuracy of traditional intra-arterial measurements. The company's focus is on addressing critical unmet healthcare needs, providing a mobile, user-friendly solution for monitoring cardiovascular health.

Amplified Sciences LLC is a molecular diagnostics company focused on the early detection of debilitating diseases, particularly pancreatic cancer and kidney disease. Utilizing an ultra-sensitive molecular sensing technology licensed from Purdue University, the company’s platform can detect disease markers at the single molecule level, enabling accurate diagnosis from bodily fluids such as urine and saliva. This versatile technology is designed for scalability to point-of-care applications, allowing for effective disease screening with a favorable cost structure. Amplified Sciences has developed a working prototype and has published proof of concept data, positioning itself to meet significant unmet medical needs in diagnostics. Founded in 2016 and based in West Lafayette, Indiana, the company was previously known as Nutrabiotix.

Theromics Inc. is a biotechnology company focused on developing innovative cell therapies, particularly in the field of thermal ablation for cancer treatment. Founded in 2016 and based in West Bridgewater, Massachusetts, the company has created HeatSYNC Gel, a biopolymer thermal accelerant designed to enhance the effectiveness of microwave and radiofrequency ablation procedures. This gel improves the delivery and absorption of thermal energy in soft tissue and bone, optimizing the ablation zone's shape and volume. By increasing local tissue electrical conductivity, HeatSYNC Gel helps to prevent heat loss due to blood flow, allowing for more precise targeting of tumors and protecting surrounding healthy tissue. The gel can be administered through various methods, including syringe, laparoscope, and bronchoscope, and is intended to improve the overall efficacy of thermal ablation therapies while enabling personalized treatment approaches.

CenSyn is a brain health screening platform focused on enhancing the accessibility and efficiency of diagnosing various neurological conditions. The company has developed a handheld EEG monitoring device aimed at accelerating the screening process for Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software facilitates long-term management of brain health by allowing clinicians to wirelessly monitor and record brain electrical activity in real time. This innovative approach enables the rapid detection of altered mental status, supporting timely diagnosis and immediate treatment, ultimately reducing inpatient costs and improving care for diverse patient populations.

Lapovations is a healthcare company founded in 2016 and headquartered in Fayetteville, Arkansas. It focuses on the development and manufacturing of innovative medical devices specifically designed for laparoscopic surgery. The company's mission is to redefine laparoscopy by creating devices that minimize invasiveness, simplify surgical procedures, and enhance patient outcomes. Through its cutting-edge technology, Lapovations aims to enable medical professionals to perform surgeries with greater safety and efficiency.

Eyebot is a company focused on revolutionizing eye examination technology to enhance access to vision care. They have developed a freestanding self-service vision testing terminal that allows users to receive accurate eye prescriptions directly at the point of sale. This automated experience aims to reduce barriers to obtaining eye care, making it easier and more efficient for individuals to address their vision needs. By providing ophthalmologists with a proactive tool for eye examinations, Eyebot contributes to improved quality of life for patients while also facilitating cost savings within the healthcare system.

Alerje, Inc. is a company based in Detroit, Michigan, specializing in emergency medicine and digital oral immunotherapy management for individuals with food allergies. Founded in 2015, Alerje has developed an innovative epinephrine auto-injector designed to fit within a smartphone case, enhancing patient adherence and emergency response capabilities. The accompanying mobile application allows users to create personalized food allergy profiles, share this information with their CareCircle—comprising family, friends, caregivers, and medical professionals—and receive location alerts. Additionally, the platform enables users to filter recipes and scan grocery items for potential allergens, thereby improving dietary decision-making. Alerje's system has been validated by the National Science Foundation, emphasizing its commitment to enhancing the quality of life for those affected by food allergies.

Mente develops a surgical instruments tracking system aimed at enhancing the surgical experience while minimizing costs for hospitals, surgical teams, and patients. The company's innovative approach employs predictive analytics to monitor surgical instruments in the operating room, generating reliable, real-time data streams. This technology significantly improves resource management, ensuring that healthcare teams have the necessary tools readily available during surgeries. By focusing on efficiency and effectiveness, Mente seeks to transform the operational dynamics of surgical procedures.

Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.

CerFlux specializes in personalized medicine technology designed to enhance cancer treatment by matching patients with the most effective therapies for their specific tumors. The company's innovative tests identify the most efficient and effective treatment options for individual patients, allowing healthcare practitioners to distinguish optimal therapies from less effective ones. This approach aims to improve patient outcomes and quality of life while minimizing the time, pain, and costs associated with cancer treatment. By focusing on personalized treatment efficacy, CerFlux contributes to a more tailored and effective healthcare experience for those battling cancer.

Emagine Solutions Technology, LLC is a Tucson, Arizona-based company specializing in mobile ultrasound imaging technology. Its flagship product, VistaScan, enables healthcare providers to convert standard mobile devices into effective ultrasound imaging tools, enhancing diagnostic capabilities. The company is currently developing its technology at the Arizona Center for Innovation, a business incubator located at the UA Tech Park. This facility offers valuable business assistance programs and resources, helping Emagine Solutions Technology advance its innovative solutions in the medical imaging field.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Quantivly, Inc. is a technology company based in Somerville, Massachusetts, that specializes in artificial intelligence solutions for radiology. Founded in 2019, it focuses on developing software that manages and analyzes MRI imaging workflows. The company's platform enables radiology providers to access a vendor-neutral, granular source of operational data by analyzing and harmonizing scanner information. This capability supports radiology departments and imaging centers in making data-driven decisions, improving operational efficiency, and enhancing patient-centered healthcare. By offering tools for data liquidity and analysis, Quantivly aims to increase access to medical imaging and drive advancements in research and patient care within the radiology sector.

Infusense is a developer of medical devices focused on delivering immediate and accurate measurements for clinical and industrial applications. The company utilizes electrochemistry to quantify lipophilic drugs, addressing unmet needs in drug safety and monitoring. Infusense's platform enables physicians to obtain real-time clinical data, allowing for faster and more personalized care by measuring drug levels directly from a drop of blood or saliva, without the need for sample processing.

EYSZ is a digital health software company based in Piedmont, California, founded in 2018. It specializes in detection algorithms that utilize oculometric and facial biometric data to reliably detect seizures and assist in the diagnosis and management of brain disorders, including epilepsy, ADHD, and depression. By employing machine learning techniques, EYSZ's software not only detects seizures but also predicts their occurrence. The platform is designed to interface and integrate with various eye-tracking systems, such as smart glasses, and therapeutic devices like neuromodulation tools, thereby enhancing the ability of clinicians to monitor and manage the neurological health of their patients effectively.

NeuroGeneces utilizes advanced neuroscience, sleep expertise, and artificial intelligence to deliver brain health assessments aimed at enhancing cognitive longevity. The company has received funding from various reputable sources, including government agencies and private investors. Its flagship product is a sleep headband equipped with machine learning algorithms that analyze EEG data, comparing it against a proprietary normative database to determine an individual's biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep patterns, including quantity, quality, and heart rate variability, providing essential support for clinicians focused on wellness and preventative care. By identifying neurodegeneration early, NeuroGeneces aims to empower users to optimize their mental and physical performance.

Malcova is an early-stage medical device startup focused on developing advanced imaging solutions for the detection and diagnosis of breast cancer, particularly in women with dense breast tissue. The company employs its proprietary Narrow-Beam Computed Tomography technology, which enhances the effectiveness of medical imaging compared to traditional methods like mammography and tomosynthesis. Additionally, Malcova integrates artificial intelligence in its software to improve the functionality of its devices. The aim is to provide clinicians with tools that facilitate accurate diagnosis while ensuring that the imaging process is safe, comfortable, and accessible for patients. Through these innovations, Malcova seeks to enhance the overall experience and outcomes for breast cancer detection and treatment.

ProMedix is a medical device startup founded in 2019 and headquartered in Portland, Oregon. The company specializes in developing noninvasive, fingertip patient monitors aimed at enhancing the recognition of circulatory dysfunction. Its innovative devices facilitate diagnostic evaluations and the monitoring of therapeutic interventions for various medical conditions, such as trauma, dehydration, and sepsis. By improving home patient monitoring, ProMedix enables physicians to streamline care in both home and critical settings, thereby preventing unnecessary acute visits and enhancing emergency or critical care outcomes.

NewHaptics is a microfluidic technology company based in Ann Arbor, Michigan, founded in 2018. The company focuses on developing innovative tactile display technology, specifically full-page digital braille and tactile graphics displays. Its primary aim is to enhance education and employment opportunities for individuals who are blind. NewHaptics offers a tablet-like device that functions as a full-page tactile display, allowing users to experience real-time digital content in a tactile format. This technology seeks to bridge the accessibility gap, providing valuable resources and experiences for the visually impaired community.

ReSuture is a company that specializes in creating high-fidelity physical simulations for surgical training, particularly focusing on open vascular procedures. Established in 2019, its primary goal is to enhance patient outcomes and minimize surgical complications by providing a superior training experience for aspiring surgeons. The company develops advanced surgical instruments that address challenges in medical simulation, allowing users to practice vascular surgical skills in a controlled environment. These instruments replicate the mechanical properties of human vascular tissue, enabling realistic simulations that improve psychomotor skills and reduce training time for medical practitioners.

PneumoNIX Medical is focused on creating gel-based technologies aimed at preventing complications related to percutaneous procedures, particularly in the context of soft tissue biopsies. The company's innovative medical devices are designed to minimize the risk of collapsed lung complications that may occur during CT-guided lung biopsies. By addressing these critical issues, PneumoNIX Medical seeks to enhance patient safety and improve outcomes in medical interventions that involve needle insertions.

VIVIFI Medical is a Houston-based company focused on developing innovative laparoscopic technology aimed at enhancing patient outcomes in men’s health. The company's flagship product is a suture-less device that facilitates the rapid connection of two blood vessels, specifically targeting conditions such as varicocele and benign prostatic hyperplasia (BPH). By improving surgical techniques for these medical issues, VIVIFI Medical seeks to provide effective solutions that surpass current treatment standards, thereby improving the quality of life for patients dealing with male infertility and related health challenges.

Moshion is a technology company specializing in healthcare workflow optimization, specifically targeting the nursing shortage. It employs 3D image sensors, preserving patient privacy, to gather movement data, which is then analyzed using machine learning models. Moshion's primary focus is to prevent pressure injuries in bedridden patients by monitoring and optimizing patient turning protocols. The platform tracks adherence to these protocols, provides personalized turn schedules, sends reminders to nurses, and automates documentation. This data-driven approach aims to enhance patient care, improve nursing efficiency, and reduce the risk of life-threatening events.

Sharper Sense is a company focused on wearable neurotechnology designed to enhance sensory acuity, including vision, hearing, and touch. The firm has developed a neuromodulation patch that employs comfortable, noninvasive electrical stimulation to improve sensory processing. This technology has both clinical and commercial applications, particularly in treating sensory processing disorders and sensory loss. By enhancing performance and safety, Sharper Sense aims to provide users with a clearer and more accurate perception of their surroundings.

OmniVis is a biotechnology company that has created an integrated portable platform for the detection of pathogens in various environments, including food processing facilities. The company offers a handheld device that quantitatively measures pathogens, providing accurate results in under 30 minutes. This technology utilizes single-use disposable test kits that analyze swabs or liquid samples, significantly reducing the time and labor associated with traditional lab testing. By delivering a low-cost and user-friendly solution, OmniVis enables health organizations to enhance their pathogen detection capabilities effectively.

CoraVie Medical is an early-stage medical device startup focused on revolutionizing blood pressure monitoring for patients with uncontrolled hypertension, who are at heightened risk for serious health issues such as kidney failure, stroke, and heart failure. The company has developed an innovative implantable continuous blood pressure monitoring solution that offers early and accurate detection of harmful blood pressure levels, providing advanced notice of changes in health status. This device connects patients and clinicians through a cloud-based software and analytics platform, facilitating timely and cost-effective clinical interventions aimed at preventing hypertension crises. By delivering actionable insights, CoraVie Medical's solution aims to improve patient outcomes and promote better management of blood pressure levels.

CPR Therapeutics is a medical device company focused on developing an advanced automated system for cardiopulmonary resuscitation (CPR). This next-generation technology integrates multiple innovations into a single, easy-to-use system designed for emergency situations. The automated CPR system enhances blood flow and the effectiveness of electrical countershocks, achieving results that were previously only possible in laboratory environments. By combining chest compressions with artificial ventilation, the system aims to preserve brain function and restore spontaneous blood circulation and breathing in individuals experiencing cardiac arrest. This technology represents a significant advancement in emergency medical care, with the potential to improve survival rates in critical situations.

Senseer Health, founded in 2017, focuses on addressing the chronic disease market by developing Smart Medical Device Therapies for managing various chronic conditions, which affect a significant portion of older adults. The company's innovations began with patented microsensors that monitor implantable devices for patients with hydrocephalus, renal, and cardiovascular diseases. To enhance the effectiveness of these microsensor-enabled devices, Senseer has incorporated advanced wearable and ambient sensor technologies. The integration of these multi-modal sensor technologies with an IoT software platform allows for the utilization of proprietary data sets and predictive analytics. This comprehensive approach provides healthcare providers with tools for remote monitoring and timely interventions, ultimately aiming to improve the quality of life for individuals with chronic conditions while reducing costs and enhancing patient safety.

Scopi Medical is a healthcare technology company specializing in next-generation medical optical imaging. It provides a hardware platform and advanced AI/ML software to enable accurate, early detection and interpretation of conditions, directly at primary care clinics. The company's innovative technology allows practitioners, with the aid of remote specialists, to visualize and treat areas of concern, such as chronic nasal conditions like rhinosinusitis, safely and efficiently.

Claria Medical is a pre-commercial medical device start-up focused on developing innovative solutions for women's healthcare, specifically targeting unmet needs in gynecologic surgery. The company specializes in creating minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has received recognition for its early achievements, including a “Safer Technologies Designation” from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private investments as well as grants from the National Science Foundation and the National Institutes of Health to support its product development efforts. By providing specialized surgical assistance, Claria Medical aims to improve outcomes for women undergoing these procedures.

Evolution Devices, Inc. is a neuro rehabilitation technology company based in Berkeley, California, focused on enhancing mobility for individuals with neurological impairments. The company’s flagship product, EvoWalk, is a bio-electronic wearable device that utilizes functional electrical stimulation and artificial intelligence to track walking patterns and personalize rehabilitation therapy. EvoWalk is designed for patients recovering from conditions such as stroke, multiple sclerosis, ALS, cerebral palsy, traumatic brain injury, and incomplete spinal cord injury. The device employs sensors that deliver electrical stimulation to leg muscles and the peroneal nerve, aiding in foot elevation during walking. This technology aims to eliminate foot drop, reduce fatigue, and minimize the risk of tripping accidents. Evolution Devices, formerly known as Foot++, Inc., was established in 2017 and rebranded in September 2019.

NeuroGeneces utilizes advanced neuroscience, sleep expertise, and artificial intelligence to deliver brain health assessments aimed at enhancing cognitive longevity. The company has received funding from various reputable sources, including government agencies and private investors. Its flagship product is a sleep headband equipped with machine learning algorithms that analyze EEG data, comparing it against a proprietary normative database to determine an individual's biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep patterns, including quantity, quality, and heart rate variability, providing essential support for clinicians focused on wellness and preventative care. By identifying neurodegeneration early, NeuroGeneces aims to empower users to optimize their mental and physical performance.

CoLabs Inc. is a medical device manufacturing company based in Morgan Hill, California, established in 2012. The company specializes in developing Ventor, an emergency airway and ventilation system designed to enhance airway management and ventilation during cardiac arrest situations. This innovative device aims to provide medical professionals with a new approach to effectively manage patients experiencing cardiac arrest, facilitating better diagnosis and treatment during critical emergencies.

Brio provides strategic resourcing solutions to the biopharma, pharmaceutical, CRO, and medical device industries. They are skilled search experts with a passion for the science and art of recruiting, introducing only the best talent to preeminent companies.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Relavo, LLC, founded in 2018 and based in Baltimore, Maryland, is a medical device company focused on improving the treatment of kidney failure patients through innovative technology. The company's flagship product, PeritoneX, is designed to enhance home dialysis by reducing the risk of infection associated with peritoneal dialysis. This in-line connection device works by disinfecting all connection points in the dialysis system before treatment, thereby aiming to minimize the occurrence of peritonitis. Relavo's approach seeks to make home dialysis safer and more accessible for patients, ultimately improving their quality of life.

Qualia Oto is a biomedical device company established in 2017 in Dallas, Texas, specializing in advanced cochlear implant technology aimed at improving the lives of individuals with hearing impairments. The company focuses on developing innovative devices that incorporate shape-changing polymers and matrix-addressed electrode arrays, which facilitate higher channel counts in cochlear implants and auditory brainstem implants. This technology allows for more precise stimulation of the auditory nerve, potentially leading to enhanced hearing capabilities. Qualia Oto's commitment to integrating machine learning into its stimulation techniques further aims to refine auditory experiences for users, addressing both medical and personal hearing needs.

Rush River Research offers mechanical and electrical design, epidemiology, and medical device project management to take ideas from concept to product. They use state-of-the-art electronics and materials. They partner with medical device companies, physicians, and academics who are also committed to improving healthcare devices.

AmCyt is focused on enhancing the efficiency of pathological analysis through a rapid onsite diagnostic device. This technology aims to improve the efficacy of biopsies while addressing labor shortages in clinics and hospitals. By allowing for real-time microscopic evaluation of tissue samples, AmCyt's device reduces the need for additional sampling and minimizes the risk of complications during procedures. Ultimately, this innovation supports healthcare providers in achieving better patient outcomes while conserving time, money, and resources.

AccuBreath is a medical device company focused on creating an affordable and ultraportable ventilator designed for respiratory support. The company has developed a non-invasive ventilation and respiration monitoring system that offers gentle assistance to patients, particularly during sedation for medical procedures. This innovative ventilator helps to reduce airway obstruction, allowing healthcare professionals to maintain effective ventilation while minimizing potential complications, such as stomach inflation. AccuBreath aims to enhance patient care through its advanced respiratory technology, making high-quality respiratory support more accessible in various medical settings.

Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.

Ai-Ris offers automated retinal examinations for primary care. Their retinal imaging system allows general practitioners to screen for diabetic retinopathy without the presence of a specialist. This system consists of a portable headset that uses machine learning algorithms to classify images of the retina of patients without dilating their pupils.

Hypersound Medical is focused on developing non-invasive neuromodulatory devices that utilize neurostimulation techniques to address chronic pain conditions. The company's products employ microwave energy to stimulate nerve cells, offering pain relief for various ailments, including arthritis, back pain, and neuropathic pain. By enhancing pain management, Hypersound Medical aims to improve patient function and reduce reliance on pain medication. Their approach encompasses various stimulation methods, such as peripheral nerve stimulation and spinal cord stimulation, positioning the company as a key player in the field of pain relief technology.

NeuRx Medical specializes in developing percutaneous thrombectomy technologies aimed at treating ischemic stroke and other vascular conditions. The company designs devices that facilitate rapid clot stabilization, retention, and retrieval during image-guided thrombectomy procedures. By addressing unmet needs in current medical systems, NeuRx Medical's innovations enable endovascular specialists to enhance patient outcomes and increase survival rates following large vessel occlusion (LVO) strokes and conditions such as deep vein thrombosis.

Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

Renerva is a growing medical device company that specializes in the development and commercialization of implantable technologies designed to enhance peripheral nerve repair procedures. The company's products aim to facilitate nerve repair, recovery, and storage, focusing on improving patient outcomes and accelerating healing processes. By providing innovative surgical devices, Renerva enables healthcare professionals to effectively assist patients in regaining function following nerve injuries.

Our mission is to promote innovation that empowers people to have the knowledge and tools to solve everyday medical problems in any setting. We do this by providing a doctor’s approach to stopping nosebleeds at your fingertips. Bleed Freeze allows people to confidently take control and treat nosebleeds anywhere.

Dynocardia, Inc. is a biomedical device company based in Massachusetts that specializes in wireless blood pressure measurement equipment. Founded in 2018, the company has developed a wrist-wearable device called ViTrack, which allows users to accurately and continuously measure vital health parameters, including blood pressure, heart rate, heart rhythm, and respiration rate. Utilizing an innovative optomechanical sensor, Dynocardia's technology offers a non-invasive method for blood pressure measurement, rivaling the accuracy of traditional intra-arterial measurements. The company's focus is on addressing critical unmet healthcare needs, providing a mobile, user-friendly solution for monitoring cardiovascular health.

Aurie is a medical device company based in New York, established in 2018. It focuses on developing a reusable urinary catheterization system aimed at improving the quality of life for individuals with disabilities. By providing a convenient, discreet, and hygienic catheterization option, Aurie seeks to reduce the risk of infections and enhance users' confidence and control over their healthcare needs. The company's innovative approach empowers users to manage their condition more effectively, enabling them to lead active and fulfilling lives.

SafeBVM is a medical device company focused on enhancing patient safety during manual ventilation. Its flagship product, Sotair, is designed to mitigate the risks associated with excessive ventilation, which can lead to complications such as stomach insufflation and acute respiratory distress syndrome. The device employs a flow-blocking and pressure-control valve mechanism that regulates airflow and ensures optimal ventilation parameters based on individual patient needs, including airway resistance and lung compliance. By addressing the issue of inadvertent hyperventilation, SafeBVM aims to improve the safety and effectiveness of manual resuscitation techniques used by healthcare providers.

Isolere Bio is a biotechnology company dedicated to simplifying the purification of biotherapeutics, particularly monoclonal antibodies and Adeno-Associated Viruses (AAV). Co-founded with the aim of enhancing global access to essential drugs, Isolere Bio develops innovative manufacturing technologies that utilize a straightforward Tangential Flow Filtration (TFF) setup. This approach facilitates a seamless transition from laboratory-scale processes to large-scale industrial production, thereby improving efficiency within the bioprocessing industry. As monoclonal antibodies continue to gain prominence as effective therapeutics and important research tools, Isolere Bio's work plays a crucial role in advancing the development of new diagnostics and treatments.

Reselute is a medical technology company focused on addressing orthopedic implant-related infections. The company specializes in designing, developing, and validating innovative orthopedic spacers that serve as a treatment solution. By leveraging advanced technologies, Reselute aims to enhance the efficiency of medical treatments and improve patient care, ultimately assisting healthcare providers in delivering timely and effective interventions for their patients.

Pathotrak, LLC, founded in 2016 and based in College Park, Maryland, develops innovative food safety testing kits that significantly enhance the detection of food-borne pathogens, such as Salmonella and E. coli. Utilizing advanced microfiltration technology, Pathotrak's kits reduce the testing time from 1-2 days to just 6 hours, streamlining the traditional 22-hour enrichment process. This rapid detection capability not only ensures compliance with FDA and USDA regulations but also integrates seamlessly into existing detection systems. By minimizing holding times and associated costs, as well as enabling quicker product releases, Pathotrak's technology aims to transform food safety practices and logistics in the industry, ultimately helping to prevent dangerous outbreaks and improve overall food safety.

Psyonic, Inc. specializes in developing advanced bionic limbs aimed at enhancing the lives of individuals with amputations. Founded in 2015 and headquartered in Champaign, Illinois, the company focuses on creating accessible, affordable solutions for its users. Its flagship product, an advanced bionic hand, is notable for its speed, ease of control, and ability to provide sensory feedback. The hand utilizes muscle pattern recognition and machine learning algorithms, allowing for customization based on the user's specific needs and preferences. Designed to withstand impacts, the bionic hand is intended to enable users to perform daily tasks with greater ease. Psyonic's goal is to ensure that the costs associated with its products are fully covered by insurance, minimizing out-of-pocket expenses for consumers.

Open Source Instruments specializes in the manufacturing of advanced equipment tailored for astrophysicists, enhancing their capacity to collect spectral data from distant galaxies. The company offers a range of products, including telemetry devices, survey cameras, a two-camera wire position sensor, an implantable stimulator, and an implantable accelerometer. These instruments enable clients to deliver variable-intensity visible and infrared illumination, facilitating more effective research and exploration in the field of astrophysics.

Monogram Orthopaedics is a medical equipment manufacturing company. Monogram Orthopaedics develops a solution architecture for enabling the mass personalization of orthopaedic implants by linking 3D printing and robotics via automated digital image analysis algorithms. They offer a delivery solution for patient-specific load-bearing joint replacements. Monogram Orthopaedics is paving the way for the future of joint replacement surgery.

Bired Imaging specializes in infrared imaging technology aimed at enhancing breast cancer detection and localization, particularly in patients with dense breast tissue. Their medical imaging platform employs thermography and a proprietary computerized detection algorithm, which allows for the accurate identification of tumor size and location. This innovative approach enables healthcare professionals to detect high-risk patients at earlier stages, improving screening efficacy while also being cost-effective. Bired Imaging's solutions serve as an important adjunctive technology in breast cancer screening, contributing to more precise diagnostic processes.

CereVu Medical focuses on enhancing patient care through an advanced pain management system. Their innovative solution features a small, wearable, single-use patch that adheres to a patient’s forehead, linking to a reusable monitoring console. This system employs proprietary algorithms and signal processing techniques to analyze personalized cerebral hemodynamic information. By doing so, it allows physicians to continuously assess a patient's pain levels and monitor the effectiveness of prescribed treatments, ensuring that care is tailored to individual patient needs.

OsciFlex LLC, founded in 2017 and based in Philadelphia, Pennsylvania, specializes in developing a wearable medical device aimed at preventing blood clots in patients. The device functions by stimulating calf muscle contractions through a muscle stretch reflex, which promotes valve sinus recirculatory flow. This innovative approach helps to prevent venous thromboembolism (VTE), a serious condition that can lead to significant health complications. By offering an alternative to traditional anti-coagulation pharmaceuticals, which can be costly and carry risks, OsciFlex aims to enhance patient care and reduce healthcare costs associated with blood clot management.

IntuiTap Medical, established in 2016 and based in Houston, Texas, specializes in manufacturing innovative medical devices. Its flagship product is a handheld device designed to enhance the precision and efficiency of spinal punctures, such as lumbar punctures, spinal anesthesia, and epidurals. This device, the first of its kind, integrates imaging technology with needle guidance and analytics, aiming to eliminate the guesswork, frustration, and pain traditionally associated with these procedures. By improving accuracy and efficiency, IntuiTap's solution aims to reduce procedural costs and instill confidence in both clinicians and patients.

MBF Therapeutics, Inc. is a veterinary oncology company that specializes in developing and commercializing innovative therapies for cancer treatment in dogs and cats. The company's product portfolio features targeted immunotherapies and small molecule drugs designed to disrupt tumor cell metabolism while sparing healthy tissues. Key products include MBFT-101, a combination therapy for sarcomas and lymphoma that utilizes a proprietary polyamine transport inhibitor alongside a potent inhibitor of ornithine decarboxylase, and MBFT-102, an immunotherapy based on the tumor suppressor/cytokine mda-7/IL24, which has shown promise in human clinical trials for various advanced cancers. Additionally, MBF Therapeutics is advancing a gene-based vaccine platform aimed at improving treatments for both cancer and infectious diseases in animals, with the potential to transform veterinary medicine. The company is located in Ambler, Pennsylvania, and maintains a strategic partnership with the Lankenau Institute for Medical Research.

Huxley Medical is a private company focused on the development of medical devices. The company operates a flexible medical platform that aims to ensure continuity of care for patients, regardless of their location or healthcare system. By collaborating with leading clinicians and basic science researchers, Huxley Medical creates and markets innovative devices and algorithms. This approach enhances user access to a wide range of disease diagnoses and treatment options, ultimately improving patient care and outcomes.

Coreless Technologies specializes in the design and manufacture of hollow metal nanoparticles, focusing on enhancing the performance of nano-enabled devices. The company has developed a continuous flow process for large-scale production of these nanoparticles, allowing for precise control over their size, shape, and optical properties. This innovation is particularly beneficial for military applications in potentially contaminated zones, as well as for addressing healthcare challenges in rural areas with limited access. Additionally, Coreless Technologies aims to support agricultural practices by providing solutions for the detection of plant-based diseases.

Atom Limbs is focused on advancing the field of prosthetics with its innovative mind-controlled artificial arms, specifically designed for under-elbow amputees and individuals with quadriplegia. The company’s flagship product, the Atom Touch, allows users to regain mobility by interpreting brain signals through implanted electrodes, facilitating natural and intuitive movement of the prosthetic limb. This technology is rooted in research and development conducted at the Johns Hopkins University Applied Physics Laboratory and has received substantial funding from DARPA. Atom Limbs aims to enhance the quality of life for those with mobility challenges by providing advanced, customizable solutions for artificial limbs.

EYSZ is a digital health software company based in Piedmont, California, founded in 2018. It specializes in detection algorithms that utilize oculometric and facial biometric data to reliably detect seizures and assist in the diagnosis and management of brain disorders, including epilepsy, ADHD, and depression. By employing machine learning techniques, EYSZ's software not only detects seizures but also predicts their occurrence. The platform is designed to interface and integrate with various eye-tracking systems, such as smart glasses, and therapeutic devices like neuromodulation tools, thereby enhancing the ability of clinicians to monitor and manage the neurological health of their patients effectively.

Quadralynx specializes in the development of wearable biometric devices tailored for adults experiencing motor speech disorders, particularly those who face challenges with volume control due to Parkinson's disease and similar neurological conditions. The company's innovative device employs biofeedback technology to alert users through vibrations when their voice reaches a pathological state. By focusing on speech and voice improvement, Quadralynx aims to enhance the quality of life for individuals affected by these disorders.

CorInnova Incorporated, founded in 2004 and based in Houston, Texas, specializes in device-based therapies aimed at treating congestive heart failure. The company is known for its innovative non-blood-contacting soft robotic cardiac assist device, which has the potential to significantly increase the number of heart failure patients eligible for life-saving device therapies. By focusing on advanced technological solutions, CorInnova seeks to improve outcomes for individuals suffering from this serious condition.

Averto Medical is a manufacturer of medical devices focused on addressing gastrointestinal diseases. The company specializes in developing innovative solutions designed to facilitate minimally invasive colorectal tumor removal, which aims to reduce the need for multiple surgical procedures and associated complications. By providing effective medical care options for patients suffering from gastrointestinal disorders, Averto Medical seeks to improve patient outcomes and streamline treatment processes in this critical area of healthcare.

Cision Vision is a developer and supplier of advanced imaging medical products focused on enhancing the examination of lymph nodes. Their innovative technology allows pathologists to visualize, scan, and record lymph nodes in real time with high contrast, without the need for injections or radiation. This capability supports the modernization of pathology practices, ensuring consistency and high-quality care in medical diagnostics. By providing these biotechnology tools, Cision Vision aims to improve the efficiency and accuracy of lymph node assessments in clinical settings.

BioSapien is a pre-clinical biotechnology company focused on creating innovative biodegradable implantable products for oncology applications. The company is developing a 3D-printed drug delivery platform that utilizes a biodegradable mesh to deliver active pharmaceutical ingredients (APIs) directly to tumor sites, thereby minimizing systemic side effects associated with traditional therapies. Their flagship product, the MediChip, is designed to administer FDA-approved high-dose systemic therapies in a localized and sustained manner, enhancing the quality of patient care. Current research is focused on applications for pancreatic and lung cancers, with plans to expand the pipeline to include other types such as colorectal, breast, and stomach cancers. By targeting drug delivery directly to cancerous tissues, BioSapien aims to improve treatment efficacy while reducing toxicity for patients.

Aspero Medical, Inc. is a medical device manufacturer based in Boulder, Colorado, established in 2018. The company specializes in gastrointestinal balloon endoscopy procedures, offering a product known as the AP Balloon Overtube. This innovative device utilizes pillar micro-texture technology to improve the performance of endoscopic procedures by enhancing mucosal wall traction and anchoring consistency within the gastrointestinal tract. By optimizing these aspects, Aspero Medical aims to reduce procedure time and sedation requirements, ultimately improving patient outcomes and providing cost-effective solutions for healthcare providers.

Eyebot is a company focused on revolutionizing eye examination technology to enhance access to vision care. They have developed a freestanding self-service vision testing terminal that allows users to receive accurate eye prescriptions directly at the point of sale. This automated experience aims to reduce barriers to obtaining eye care, making it easier and more efficient for individuals to address their vision needs. By providing ophthalmologists with a proactive tool for eye examinations, Eyebot contributes to improved quality of life for patients while also facilitating cost savings within the healthcare system.

ColoWrap, LLC is a medical device company based in Durham, North Carolina, focused on enhancing the colonoscopy experience. Founded in 2012, the company has developed a non-invasive device designed to prevent looping in the colon during procedures. This device applies sustained, adjustable pressure to the lower abdomen, specifically targeting the sigmoid and transverse colon, which reduces the need for manual pressure and frequent patient repositioning. Made from latex-free materials similar to those used in high-performance wetsuits, the device aims to improve patient comfort while allowing medical practitioners to perform colonoscopies with minimal invasion.

Envivo Bio develops a non-invasive device that collects microbiome samples from all regions of the human gastrointestinal tract. The company is based in San Carlos, California.

Precision Neuroscopics is a medical device company located in Pittsburgh, Pennsylvania, specializing in the development of advanced high-density electroencephalography (EEG) systems. These innovative systems are designed to non-invasively detect brain signals that indicate worsening traumatic brain injuries. The company's focus is on creating engineering technologies that enhance the density, durability, and usability of brain recording systems. By improving the quality of EEG signal recordings, Precision Neuroscopics aims to assist clinicians in reducing clinical time and costs associated with brain monitoring, ultimately enhancing patient care.

Clairways specializes in smart lung monitoring technology designed for pharmaceutical clinical trials. The company develops a wearable digital lung monitor that captures critical respiratory metrics for individuals suffering from conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). Fitted to the body, this device employs acoustic sensors and machine learning technology to detect and characterize various respiratory metrics. The collected data is presented in an accessible format, allowing healthcare providers to easily monitor and assess patients' respiratory health over the long term.

Green Sun Medical, LLC is a medical device company based in Fort Collins, Colorado, specializing in the design, development, and manufacturing of orthotic braces for treating Adolescent Idiopathic Scoliosis (AIS) and Kyphosis. Founded in 2013, the company focuses on creating a dynamic spinal alignment brace that applies continuous corrective pressure to the spine, assisting in the management of spinal deformities. This innovative brace not only promotes effective treatment but also enables physicians to monitor its performance remotely in real-time, thereby enhancing patient care and recovery outcomes. Green Sun Medical is dedicated to advancing spinal health through its technology-driven solutions.

CollaMedix specializes in the development of collagen-based medical devices aimed at addressing soft tissue repair and augmentation. The company focuses on treating stress urinary incontinence in women, a condition that results in urine leakage during activities such as laughing, coughing, sneezing, lifting, and exercising. CollaMedix utilizes proprietary collagen materials to create a bio-inductive scaffold, which is a strong fabric designed to support human tissue and facilitate rapid cell integration. This innovative approach allows researchers to explore new and effective treatments for female pelvic health, ensuring safety and efficacy in their medical solutions.

xMD Diagnostics, based in Annapolis, Maryland, specializes in biotechnology within the healthcare sector. The company develops molecular diagnostics tools that use high-throughput microdissection technology to improve cancer diagnosis and management. These tools are designed to isolate, procure, and enrich cells of interest from biopsy and other specimen samples. This process facilitates various downstream analyses, including PCR, genomic or proteomic testing, and next-generation sequencing. By enhancing the capabilities of clinical and research laboratories, xMD Diagnostics supports pathologists, oncologists, and other healthcare professionals in diagnosing, monitoring, and treating patients with cancer and serious genetic diseases.

Synopic is developing advanced imaging technology aimed at enhancing visualization and decision-making in medical procedures. The company focuses on creating a next-generation depth-enabled camera that captures measurable 3D information, specifically designed for applications like endoscopy and other minimally invasive procedures where instrument space is limited. By employing a single-camera implementation, Synopic addresses the challenges of integrating high-resolution color imaging with spatial and depth information, which current technologies struggle to achieve. This innovative approach allows for the creation of ultracompact imaging devices that provide improved visualization and data, ultimately facilitating better outcomes in medical practice.

Niche Biomedical is a platform and therapy development firm that specializes in creating innovative solutions for chronic injuries and disorders that have not responded to traditional pharmacological treatments. The company has developed ANEUVO®, which focuses on addressing these challenging medical conditions. Among its notable innovations is ExaStim®, a non-invasive neuromodulation system that has received FDA Breakthrough Device Designation for the treatment of spinal cord injuries. Additionally, Niche Biomedical is advancing a gastrointestinal therapeutic device aimed at alleviating postoperative ileus and restoring gastrointestinal motility. This device leverages bioelectronic medicine to revolutionize treatment options for various diseases and injuries that are difficult to manage with conventional pharmaceuticals. The company is also capable of developing miniaturized implantable devices that maintain sophisticated functionality, allowing for targeted neuromodulation therapies.

SpineX Inc. is a seed-stage medical device company focused on developing non-invasive neuromodulation devices aimed at addressing unmet medical needs in patients with neurological conditions. The company is engaged in clinical trials to evaluate the safety and effectiveness of its neuromodulation therapy specifically for individuals suffering from neurogenic bladder issues related to stroke, spinal cord injuries, or multiple sclerosis. SpineX's technologies are designed to enhance recovery and restore various functions, including bladder, bowel, respiration, sexual, and sensorimotor capabilities. One of its key products, the SCiP device, targets neurological dysfunction associated with conditions like cerebral palsy. By leveraging rigorously tested neuromodulation methods, SpineX aims to improve the quality of life for individuals affected by these debilitating conditions.

Ecate, founded in 2020 and based in Los Angeles, California, is focused on developing advanced medical devices that create neural interfaces to bridge the gap between human and machine intelligence. The company utilizes nanoparticles and nanotechnology to engineer bi-directional neural interfaces equipped with customized nanopatterned electrodes. This innovative technology aims to restore sensory and motor communication for individuals with paralysis, enabling them to regain control of lost functions and improve their quality of life.

Infusense is a developer of medical devices focused on delivering immediate and accurate measurements for clinical and industrial applications. The company utilizes electrochemistry to quantify lipophilic drugs, addressing unmet needs in drug safety and monitoring. Infusense's platform enables physicians to obtain real-time clinical data, allowing for faster and more personalized care by measuring drug levels directly from a drop of blood or saliva, without the need for sample processing.

Compact Medical Solutions LLC is a company that specializes in developing innovative medical devices, specifically a bag-valve-mask (BVM) known as the Butterfly BVM. Founded in 2016 and headquartered in Indianapolis, Indiana, the company focuses on creating an ultra-compact breathing device that aids medical personnel in managing emergency breathing situations. The Butterfly BVM enhances resuscitation efforts by preventing hyperventilation, thereby allowing for safer ventilation of patients experiencing respiratory distress.

Frontier Bio Corporation, based in Oakland, California, develops and manufactures advanced bioprinting technologies to create lab-grown human tissues. Established in 2018, the company offers the FLUX-1, a 3D bioprinter that integrates conventional bioprinting methods with electro-hydrodynamic printing capabilities. This technology enables the production of complex tissues, such as skin, cartilage, and bone, while also facilitating drug toxicity testing, tissue implants, drug screening, and disease modeling. Frontier Bio aims to replace animal studies with ethically developed human tissues, ultimately working towards eliminating the organ transplant waitlist and improving patient outcomes. The company focuses on achieving complete cell survivability during the printing process, ensuring the viability of the printed tissues for various medical applications.

Empo Health specializes in in-home health monitoring solutions that enhance patient care by integrating seamlessly into daily life. The company has developed an innovative imaging bathroom scale and a digital health platform aimed at detecting early signs of diabetic foot conditions, thereby helping to prevent amputations. By providing reliable visual data outside of clinical settings, Empo Health enables both patients and clinicians to monitor health effectively and maintain standards of care. Through its advanced technology, the company seeks to improve health outcomes and foster proactive management of chronic conditions.

ZelosDx specializes in the development of blood testing products aimed at advancing research in brain health and diseases. The company provides researchers with access to proprietary technology that can be licensed and adapted for blood testing kits and automated laboratory equipment. Additionally, it offers pharmaceutical collaborators biomarker technology to support drug discovery efforts. By delivering critical data for diagnosis, monitoring, and evaluating therapeutic responses, ZelosDx facilitates significant advancements in the understanding and treatment of brain-related conditions.

KovaDx focuses on improving healthcare access for individuals suffering from Sickle Cell Disease and other hemolytic anemias through an innovative point-of-care solution. The company has developed a health monitoring tool that utilizes Quantitative Phase Imaging and deep learning technology to provide affordable and easy-to-use diagnostics. This system is designed to bridge gaps in care for blood diseases, enabling better management of blood health. By offering a diagnostic and monitoring device, KovaDx aims to enhance the understanding of treatment impacts and improve patient outcomes. Ultimately, the company seeks to support individuals with Sickle Cell Disease in enhancing their overall prognosis and quality of life.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Sequitur Health, founded in 2019 and based in Scottsdale, Arizona, specializes in the development of innovative medical devices aimed at enhancing patient care and improving quality of life. The company focuses on addressing unmet needs of patients and physicians by leveraging technological advancements. By collaborating with educational and medical institutions in Arizona, Sequitur Health creates solutions that enable healthcare providers to deliver timely and effective care to patients.

Emagine Solutions Technology, LLC is a Tucson, Arizona-based company specializing in mobile ultrasound imaging technology. Its flagship product, VistaScan, enables healthcare providers to convert standard mobile devices into effective ultrasound imaging tools, enhancing diagnostic capabilities. The company is currently developing its technology at the Arizona Center for Innovation, a business incubator located at the UA Tech Park. This facility offers valuable business assistance programs and resources, helping Emagine Solutions Technology advance its innovative solutions in the medical imaging field.

Theromics Inc. is a biotechnology company focused on developing innovative cell therapies, particularly in the field of thermal ablation for cancer treatment. Founded in 2016 and based in West Bridgewater, Massachusetts, the company has created HeatSYNC Gel, a biopolymer thermal accelerant designed to enhance the effectiveness of microwave and radiofrequency ablation procedures. This gel improves the delivery and absorption of thermal energy in soft tissue and bone, optimizing the ablation zone's shape and volume. By increasing local tissue electrical conductivity, HeatSYNC Gel helps to prevent heat loss due to blood flow, allowing for more precise targeting of tumors and protecting surrounding healthy tissue. The gel can be administered through various methods, including syringe, laparoscope, and bronchoscope, and is intended to improve the overall efficacy of thermal ablation therapies while enabling personalized treatment approaches.

Hermes Life Sciences develops solutions to improve the accuracy and accessibility of blood testing at the point of care. The company was founded by Sasank Vemulapati.

NeuroTechR3 is a biomedical device and digital health start-up that focuses on developing affordable rehabilitation technologies to enhance upper extremity function for individuals affected by brain injuries, including stroke and cerebral palsy. The company's flagship innovation, R3THATM, leverages machine learning and cloud technology to enable personalized telerehabilitation through engaging exergames designed to foster neuroplasticity. This system includes features such as motion tracking, analytics, and real-time biofeedback, which help clinicians provide high-quality, efficient care while improving patient recovery outcomes. Founded in 2020 by a team of four women, NeuroTechR3 emerged from the New Jersey Institute of Technology and Rutgers University, and operates from locations in Newark, NJ, and Philadelphia, PA. The company's expertise lies in biomedical engineering and computer science, positioning it to address the needs of the rehabilitation industry effectively. By advancing rehabilitation devices and machine learning-driven technologies, NeuroTechR3 aims to transform healthcare and make rehabilitation more accessible and sustainable for individuals with various impairments.

EnVision Endoscopy specializes in developing medical devices for endoscopic surgeries, focusing on enhancing clinical outcomes for patients and efficiency for healthcare providers. The company's flagship product is an image-guided suturing system that attaches to standard flexible endoscopes, facilitating tissue approximation during surgical procedures. This biodegradable, single-use device simplifies various surgical tasks, making it more accessible for gastroenterologists and surgeons. By streamlining procedures, EnVision Endoscopy aims to reduce both procedure times and associated mortality rates, thereby improving overall patient care in the medical field.

Cordance Medical is a medical device company focused on developing innovative therapies for central nervous system (CNS) pathologies, including primary and metastatic cancers, Alzheimer's disease, and Parkinson's disease. The company has created a non-invasive ultrasound system that precisely opens the blood-brain barrier, allowing for targeted delivery of systemically administered drugs to specific brain regions. This low-power ultrasound technology aims to enhance diagnostic and therapeutic options for patients, providing a safe and effective means to address complex neurological conditions.

Alerje, Inc. is a company based in Detroit, Michigan, specializing in emergency medicine and digital oral immunotherapy management for individuals with food allergies. Founded in 2015, Alerje has developed an innovative epinephrine auto-injector designed to fit within a smartphone case, enhancing patient adherence and emergency response capabilities. The accompanying mobile application allows users to create personalized food allergy profiles, share this information with their CareCircle—comprising family, friends, caregivers, and medical professionals—and receive location alerts. Additionally, the platform enables users to filter recipes and scan grocery items for potential allergens, thereby improving dietary decision-making. Alerje's system has been validated by the National Science Foundation, emphasizing its commitment to enhancing the quality of life for those affected by food allergies.

Airity Technologies is a deep-tech startup focused on power electronics, specializing in the development of advanced power supply units and conversion products. The company is dedicated to creating innovative circuit topologies that lead to extremely compact and power-dense high-voltage sources, offering units that are significantly smaller and more efficient than traditional alternatives. Airity's technology enables the generation of plasma in various environments, including open atmospheres and different gas mixtures under partial and hard vacuum conditions. This innovation serves multiple industries, including semiconductor, aerospace, telecommunications, and medical sectors, providing them with access to compact power supplies that enhance performance and reduce costs.